An Exploratory Study of MSLN-CAR T Cells Secreting PD-1 Nanobodies for the Treatment of MSLN-positive Advanced Solid Tumors
Latest Information Update: 06 Dec 2022
At a glance
- Drugs BZDS 1901 (Primary) ; Cyclophosphamide
- Indications Mesothelioma; Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology
- 04 Aug 2020 As per this link (https://www.bloomberg.com/profile/company/1686139D:CH) Shanghai Cell Therapy Group Co.,Ltd , is biotech and pharma so added in association.
- 04 Aug 2020 New trial record